Effects of miRNAs on myocardial apoptosis by modulating mitochondria related proteins

Yanfang Zhao1, Murugavel Ponnusamy1, Yanhan Dong1

  • 1Centre for Developmental Cardiology, Institute for Translational Medicine, Qingdao University, Qingdao, China.

Insights

MicroRNAs regulate mitochondrial apoptosis in heart cells, impacting cardiovascular diseases like heart failure and myocardial infarction. Understanding these mechanisms offers new therapeutic targets for cardiac mitochondrial dysfunction.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Myocardial apoptosis, particularly the intrinsic mitochondrial pathway, is crucial in cardiovascular disease pathogenesis.
  • Mitochondrial dynamics (fission/fusion) and apoptosis are implicated in heart failure, myocardial infarction, and diabetic cardiomyopathy.
  • MicroRNAs (miRNAs) are key regulators of gene expression, influencing cardiac signaling and cellular events.

Purpose of the Study:

  • To review the molecular mechanisms of mitochondrial apoptosis in cardiac cells.
  • To elucidate the regulatory role of miRNAs in cardiac mitochondrial apoptosis.
  • To identify potential therapeutic targets for cardiovascular diseases linked to mitochondrial dysfunction.

Main Methods:

  • Literature review focusing on molecular mechanisms of mitochondrial apoptosis.
  • Analysis of miRNA regulation of mitochondrial dynamics, ROS, calcium homeostasis, and Bcl-2 family proteins.
  • Synthesis of current understanding of miRNA-mediated control of cardiac cell death.

Main Results:

  • MiRNAs modulate cardiac mitochondrial apoptosis by influencing mitochondrial fission/fusion, ROS generation, and calcium homeostasis.
  • MiRNAs target key proteins in the mitochondrial apoptosis pathway, including Bcl-2 family members.
  • Dysregulation of these miRNA-mediated pathways contributes to cardiovascular pathologies.

Conclusions:

  • MiRNAs are critical regulators of mitochondrial apoptosis in the heart.
  • Targeting miRNA-mediated pathways offers a promising therapeutic strategy for cardiovascular diseases.
  • Further research into these mechanisms can lead to novel treatments for heart conditions involving mitochondrial dysfunction.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K